Showing results (11-20 of 74) with videos related to
Sort By:
Pageof 8
Expert Opinion on Investigational Drugs|January 5, 2002
Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infectionsA H Groll, T J WalshKlinische Padiatrie|September 29, 2001
[Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer]A H Groll, J Ritter, F M MüllerCurrent Opinion in Pediatrics|March 20, 1999
Treatment of fungal infections in neutropenic childrenT Lehrnbecher, A H Groll, S J ChanockKlinische Padiatrie|September 29, 2001
[Prevention of fungal infections in children and adolescents with cancer]A H Groll, J Ritter, F M MüllerPharmacotherapy|August 15, 2001
Antifungal pharmacodynamics: concentration-effect relationships in vitro and in vivoA H Groll, S C Piscitelli, T J WalshKlinische Padiatrie|November 17, 2005
[Antimicrobial agents in pediatric cancer patients with hepatic or renal impairment]H Kolve, G Silling, J Ritter, et al.Klinische Padiatrie|November 17, 2005
[Drug interactions of antimicrobial agents in children with cancer]C Langebrake, S Uhlenbrock, J Ritter, et al.European Journal of Pediatrics|March 27, 1999
Current approaches to diagnosis and treatment of fungal infections in children infected with human immuno deficiency virusF M Müller, A H Groll, T J WalshThe Oncologist|May 5, 2000
New drugs and novel targets for treatment of invasive fungal infections in patients with cancerC C Chiou, A H Groll, T J WalshKlinische Padiatrie|May 12, 2006
Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomideK Ehlert, A H Groll, J Kuehn, et al.Pageof 8